UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
via Google News
The Latest on: Molecular diagnostics
- Award to help advance development of diagnostic test for necrotizing enterocolitison December 9, 2019 at 9:39 am
Based on an LSU Health New Orleans research breakthrough, the award will advance the development and commercialization of a noninvasive diagnostic biomarker test for necrotizing enterocolitis invented ...
- Molecular Diagnostics Market Size, Share | Segmentations, Analysis, Insights, Forecast, Research Report 2025on December 9, 2019 at 5:47 am
The global molecular diagnostics market is projected to grow with rising technological developments in molecular diagnostic techniques. These advancements are intended to offer higher accuracy, ...
- Molecular Diagnostics Equipment Market Analysis by Key Players, End Users, Application and CAGR Value Forecast to 2028on December 9, 2019 at 1:46 am
Dec 09, 2019 (WiredRelease via COMTEX) -- An extensive and elaborate primary research on Global Molecular Diagnostics Equipment Market report sheds light on numerous facets such as growth factors, ...
- Diagnostic Pathology: Molecular Oncology. Edition No. 2 - ResearchAndMarkets.comon December 6, 2019 at 1:14 am
Vasef, Mohammad A. Professor of Pathology, The University of New Mexico Health Sciences Center, Albuquerque, New Mexico. Auerbach, Aaron Staff Pathologist, Department of Hematopathology, The Joint ...
- Global Molecular Diagnostics Partnering Deals 2014-2019 by Deal Type, Industry Sector, Stage Of Development, Technology Type, Therapeutic Indicationon December 5, 2019 at 4:08 pm
DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The "Global Molecular Diagnostics Partnering Terms and Agreements 2014 to2019" report has been added to ResearchAndMarkets.com's offering. The Global Molecular ...
- BRIEF-FDA Authorizes Roche Molecular Systems' cobas vivoDx MRSA Diagnostic Teston December 5, 2019 at 11:29 am
U.S. Food and Drug Administration: * U.S. FDA - AUTHORIZED MARKETING OF NEW DIAGNOSTIC TEST TO DETECT METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS BACTERIAL COLONIZATION * FDA SAYS GRANTED MARKETING ...
- Global Molecular Diagnostics Partnering Terms and Agreements Directory 2014-2019on December 5, 2019 at 2:18 am
Dublin, Dec. 05, 2019 (GLOBE NEWSWIRE) -- The "Global Molecular Diagnostics Partnering Terms and Agreements 2014 to2019" report has been added to ResearchAndMarkets.com's offering. The Global ...
- Co-Diagnostics JV CoSara Receives Indian Regulatory Approval for Five Diagnostic Assayson December 3, 2019 at 4:05 pm
and human papillomavirus now available for sale and distribution as in vitro diagnostics Co-Diagnostics, Inc. (CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform ...
- $50M deal could expand NanoString Technologies diagnostic test into more marketson December 3, 2019 at 11:09 am
NanoString, which creates devices for molecular diagnostics and research tools to understand diseases and develop drugs, will record more than $100 million in revenue this year. Gray compared the ...
- Infectious Disease In Vitro Diagnostic (IVD) & Molecular Test Markets - Worldwide Analysis & Forecast, 2019-2023on December 3, 2019 at 7:18 am
Dublin, Dec. 03, 2019 (GLOBE NEWSWIRE) -- The "Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market: Size, Trends and Forecasts (2019-2023)" report has been added to ...
via Bing News